Generali Investments Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.55M Buy
58,747
+15,556
+36% +$1.82M 1.64% 11
2026
Q1
$5.2M Sell
43,191
-5,969
-12% -$689K 1.21% 18
2025
Q4
$5.17M Buy
49,160
+11,966
+32% +$1.12M 1.03% 21
2025
Q3
$3.12M Buy
37,194
+11,921
+47% +$982K 0.65% 34
2025
Q2
$2M Buy
25,273
+5,911
+31% +$470K 0.45% 57
2025
Q1
$1.74M Sell
19,362
-11,087
-36% -$1.04M 0.49% 54
2024
Q4
$3.03M Buy
+30,449
New +$3.14M 0.78% 34

Other funds holding MRK

Generali Investments Management's MRK Position: Q2 2026 in Review

Generali Investments Management increased its Merck (MRK) stake by 36% in Q2 2026, buying an estimated $1.82M and bringing the position to 58,747 shares worth $7.55M. The position accounts for 1.64% of the portfolio, ranked #11.

Generali Investments Management first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Generali Investments Management held 58,747 shares of Merck worth $7.55M as of Q2 2026.
  • Generali Investments Management bought 15,556 Merck shares in Q2 2026, an estimated $1.82M.
  • Merck made up 1.64% of Generali Investments Management's portfolio in Q2 2026, its #11 holding.
  • Generali Investments Management first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Generali Investments Management's 13F filing for Q2 2026, filed 10 Jul 2026.